NO963446D0 - Surgjort nitritt som et antimikrobielt middel - Google Patents
Surgjort nitritt som et antimikrobielt middelInfo
- Publication number
- NO963446D0 NO963446D0 NO963446A NO963446A NO963446D0 NO 963446 D0 NO963446 D0 NO 963446D0 NO 963446 A NO963446 A NO 963446A NO 963446 A NO963446 A NO 963446A NO 963446 D0 NO963446 D0 NO 963446D0
- Authority
- NO
- Norway
- Prior art keywords
- antimicrobial agent
- nitrite
- sourced
- agent
- dosage form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9403284A GB9403284D0 (en) | 1994-02-21 | 1994-02-21 | Acidified nitrite as antimicrobial agent |
GB9404365A GB9404365D0 (en) | 1994-03-07 | 1994-03-07 | Acidified nitrate as antimicrobial agent |
PCT/GB1995/000338 WO1995022335A1 (en) | 1994-02-21 | 1995-02-17 | Acidified nitrite as an antimicrobial agent |
Publications (3)
Publication Number | Publication Date |
---|---|
NO963446D0 true NO963446D0 (no) | 1996-08-19 |
NO963446L NO963446L (no) | 1996-10-21 |
NO311494B1 NO311494B1 (no) | 2001-12-03 |
Family
ID=26304368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19963446A NO311494B1 (no) | 1994-02-21 | 1996-08-19 | Doseringsform for behandling av mikrobiologiske tilstander i mennesker eller dyr, fremgangsmåte for sterilisering av engjenstand, steriliserende blanding, samt dyrefôrtillegg |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0746327B1 (no) |
JP (1) | JP3875262B2 (no) |
KR (1) | KR100385297B1 (no) |
CN (1) | CN1145491C (no) |
AT (1) | ATE264685T1 (no) |
AU (1) | AU693851B2 (no) |
BR (1) | BR9507099A (no) |
CA (1) | CA2183549C (no) |
CZ (1) | CZ286286B6 (no) |
DE (1) | DE69532921T2 (no) |
DK (1) | DK0746327T3 (no) |
ES (1) | ES2218541T3 (no) |
FI (1) | FI114852B (no) |
NO (1) | NO311494B1 (no) |
PL (1) | PL180769B1 (no) |
PT (1) | PT746327E (no) |
WO (1) | WO1995022335A1 (no) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6709681B2 (en) | 1995-02-17 | 2004-03-23 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
GB9804469D0 (en) * | 1998-03-02 | 1998-04-29 | Univ Aberdeen | Antiviral composition |
SE9700617D0 (sv) * | 1997-02-21 | 1997-02-21 | Kjell Alving | New composition |
US6682732B1 (en) | 1998-08-28 | 2004-01-27 | The University Of Bath | Treatment of lesions |
GB9905425D0 (en) * | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
GB0021317D0 (en) * | 2000-08-30 | 2000-10-18 | Queen Mary & Westfield College | Transdermal pharmaceutical delivery composition |
GB0022084D0 (en) * | 2000-09-08 | 2000-10-25 | Univ Aberdeen | Treatment of multiply antibiotic-resistant organisms |
US6432077B1 (en) * | 2000-12-26 | 2002-08-13 | Sensormedics Corporation | Device and method for treatment of surface infections with nitric oxide |
GB0119011D0 (en) | 2001-08-03 | 2001-09-26 | Univ Aberdeen | Treatment of nail infections |
US20050054991A1 (en) | 2001-08-29 | 2005-03-10 | Tobyn Michael John | Topical administration device |
GB0125222D0 (en) * | 2001-10-19 | 2001-12-12 | Barts & London Nhs Trust | Composition for the treatment of microbial infections |
ATE372777T1 (de) | 2003-07-09 | 2007-09-15 | Us Gov Health & Human Serv | Verwendung von nitritsalzen zur behandlung von kardiovaskulären erkrankungen |
MX2007009691A (es) * | 2005-02-11 | 2008-02-12 | Nolabs Ab | Dispositivo y metodo para el tratamiento de dermatomicosis y, en particular, de onicomicosis. |
WO2006125123A2 (en) | 2005-05-19 | 2006-11-23 | University Of Cincinnati | Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite |
US20090214618A1 (en) | 2005-05-27 | 2009-08-27 | Schoenfisch Mark H | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
GB0604319D0 (en) * | 2006-03-03 | 2006-04-12 | Optinose As | Nasal delivery |
GB0607402D0 (en) * | 2006-04-12 | 2006-05-24 | Barts & London Nhs Trust | Therapeutic composition and use |
GB0618711D0 (en) * | 2006-09-22 | 2006-11-01 | Univ Exeter | Agricultural treatment |
WO2011022680A2 (en) | 2009-08-21 | 2011-02-24 | Novan, Inc. | Wound dressings, methods of using the same and methods of forming the same |
EP4249001A3 (en) | 2009-08-21 | 2023-11-29 | Novan, Inc. | Topical gels |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
WO2012118819A2 (en) | 2011-02-28 | 2012-09-07 | Novan, Inc. | Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same |
WO2015066278A1 (en) * | 2013-10-31 | 2015-05-07 | Advanced Plasma Therapies, Inc. | Methods for using nitric oxide in a plasma state to treat medical conditions and diseases |
AU2015274551A1 (en) * | 2014-06-13 | 2016-12-22 | Origin, Inc. | Veterinary methods for using nitric oxide in a plasma state to treat medical conditions and diseases in animals |
WO2016090366A1 (en) * | 2014-12-05 | 2016-06-09 | Can Technologies, Inc. | Animal feed supplement and method |
KR20200027951A (ko) | 2017-06-23 | 2020-03-13 | 캔 테크놀로지스 인코포레이티드 | 육류 품질 개선 방법 |
JP2023510662A (ja) | 2019-06-04 | 2023-03-15 | サーティー レスピラトリー リミテッド | 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用 |
BR112021023832A8 (pt) | 2019-06-04 | 2023-02-28 | Thirty Holdings Ltd | Métodos e composições para geração de óxido nítrico e usos dos mesmos |
WO2021214439A1 (en) | 2020-04-23 | 2021-10-28 | Thirty Respiratory Limited | Methods and compositions for treating and combatting tuberculosis |
WO2021214440A1 (en) | 2020-04-23 | 2021-10-28 | Thirty Respiratory Limited | Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2 |
GB202101543D0 (en) | 2021-02-04 | 2021-03-24 | Thirty Respiratory Ltd | Vaping e-liquid composition and the use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4191750A (en) * | 1976-03-08 | 1980-03-04 | Milton Hodosh | Method for treating canker sores |
JPS5985278A (ja) * | 1982-11-05 | 1984-05-17 | Agency Of Ind Science & Technol | 食品の保存方法及び保存材 |
JPH0622540B2 (ja) * | 1985-12-18 | 1994-03-30 | 株式会社祥光化学研究所 | 消臭抗菌能を有する構造物 |
-
1995
- 1995-02-17 BR BR9507099A patent/BR9507099A/pt not_active IP Right Cessation
- 1995-02-17 AT AT95908347T patent/ATE264685T1/de not_active IP Right Cessation
- 1995-02-17 CN CNB951921991A patent/CN1145491C/zh not_active Expired - Fee Related
- 1995-02-17 CZ CZ19962456A patent/CZ286286B6/cs not_active IP Right Cessation
- 1995-02-17 PL PL95316033A patent/PL180769B1/pl not_active IP Right Cessation
- 1995-02-17 WO PCT/GB1995/000338 patent/WO1995022335A1/en active IP Right Grant
- 1995-02-17 JP JP52166995A patent/JP3875262B2/ja not_active Expired - Lifetime
- 1995-02-17 DK DK95908347T patent/DK0746327T3/da active
- 1995-02-17 PT PT95908347T patent/PT746327E/pt unknown
- 1995-02-17 AU AU16699/95A patent/AU693851B2/en not_active Ceased
- 1995-02-17 ES ES95908347T patent/ES2218541T3/es not_active Expired - Lifetime
- 1995-02-17 CA CA002183549A patent/CA2183549C/en not_active Expired - Fee Related
- 1995-02-17 DE DE69532921T patent/DE69532921T2/de not_active Expired - Lifetime
- 1995-02-17 KR KR1019960704590A patent/KR100385297B1/ko not_active IP Right Cessation
- 1995-02-17 EP EP95908347A patent/EP0746327B1/en not_active Expired - Lifetime
-
1996
- 1996-08-16 FI FI963232A patent/FI114852B/fi active IP Right Grant
- 1996-08-19 NO NO19963446A patent/NO311494B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0746327T3 (da) | 2004-05-10 |
KR100385297B1 (ko) | 2003-10-10 |
DE69532921T2 (de) | 2005-04-14 |
BR9507099A (pt) | 1997-09-16 |
CA2183549C (en) | 2006-09-12 |
CN1144484A (zh) | 1997-03-05 |
AU693851B2 (en) | 1998-07-09 |
JP3875262B2 (ja) | 2007-01-31 |
FI114852B (fi) | 2005-01-14 |
PL316033A1 (en) | 1996-12-23 |
FI963232A0 (fi) | 1996-08-16 |
AU1669995A (en) | 1995-09-04 |
CZ286286B6 (cs) | 2000-03-15 |
CN1145491C (zh) | 2004-04-14 |
NO963446L (no) | 1996-10-21 |
EP0746327B1 (en) | 2004-04-21 |
PT746327E (pt) | 2004-06-30 |
ES2218541T3 (es) | 2004-11-16 |
CA2183549A1 (en) | 1995-08-24 |
CZ245696A3 (en) | 1997-01-15 |
ATE264685T1 (de) | 2004-05-15 |
FI963232A (fi) | 1996-09-12 |
EP0746327A1 (en) | 1996-12-11 |
JPH09508921A (ja) | 1997-09-09 |
WO1995022335A1 (en) | 1995-08-24 |
DE69532921D1 (de) | 2004-05-27 |
PL180769B1 (pl) | 2001-04-30 |
NO311494B1 (no) | 2001-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO963446L (no) | Surgjort nitritt som et antimikrobielt middel | |
WO1992019104A3 (en) | Fatty acid based compositions for the control of established plant infections | |
WO2000034265A3 (en) | Quinoline-indole antimicrobial agents | |
PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
HU9301550D0 (en) | New hydroxamine acid and n-hydroxy-carbamide derivatives and their applications | |
AU2001271545A1 (en) | Promoting whole body health | |
RS50091B (sr) | Upotreba retigabina u lečenju neuropatskog bola | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
ES2178657T3 (es) | Derivados lipopeptidos, procedimiento para su preparacion y su empleo. | |
ATE461928T1 (de) | Antibakterielle wirkstoffe | |
BR9507730A (pt) | Uso de formulações em gel como composições de tratamento | |
HK1036222A1 (en) | Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives. | |
PT964687E (pt) | Composicoes farmaceuticas com actividade antimicrobiana | |
WO1999067238A3 (en) | Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them | |
NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
RS50148B (sr) | Upotreba docetaksela za lečenje hepatoćelijskog karcinoma | |
ATE260097T1 (de) | Hopfensäuren zur hemmung von staphylococcus aureus | |
BG105120A (en) | Chemotaxis-inhibiting protein of staphylococcus (chips) and its use | |
MX9603535A (es) | Nitrito acido como un agente antimicrobiano. | |
AU2768697A (en) | Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals | |
GEP20033144B (en) | Hygromycin A Derivatives as Antibacterial Agents | |
BR0308734A (pt) | Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção | |
WO2023003882A3 (en) | Compounds having selective inactivation activity | |
MX9708385A (es) | Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas. | |
WO2002018354A8 (en) | Oxazolidinones and their use as antibacterial agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |